Menu

Question 3801

Topic: Biology, Genetics & Bone Healing

A patient with spondyloepiphyseal dysplasia (SED) congenita has widespread epiphyseal involvement and spinal abnormalities. The genetic defect responsible for this condition predominantly affects which of the following collagens?

. Type I collagen
. Type II collagen
. Type IV collagen
. Type IX collagen
. Type X collagen

Correct Answer & Explanation

. Type II collagen


Explanation

Spondyloepiphyseal dysplasia congenita is caused by mutations in the COL2A1 gene, affecting type II collagen. Type II collagen is primarily found in hyaline cartilage, including articular cartilage and the nucleus pulposus.

Question 3802

Topic: Biology, Genetics & Bone Healing

A 2-year-old presents with bowing of the lower extremities and delayed walking. Radiographs demonstrate metaphyseal flaring and lucency mimicking rickets. However, laboratory evaluation reveals normal serum calcium, normal phosphorus, and normal vitamin D levels, but notably low serum alkaline phosphatase. What is the most likely diagnosis?

. Metaphyseal chondrodysplasia, Schmid type
. X-linked hypophosphatemic rickets
. Osteogenesis imperfecta
. Hypophosphatasia
. Vitamin D dependent rickets type II

Correct Answer & Explanation

. Hypophosphatasia


Explanation

Hypophosphatasia is an inborn error of metabolism caused by mutations in the ALPL gene, leading to deficient tissue-nonspecific alkaline phosphatase. It presents with rickets-like skeletal changes but is uniquely characterized by a low serum alkaline phosphatase level.

Question 3803

Topic: Biology, Genetics & Bone Healing

A 12-year-old girl is evaluated for delayed dental eruption and abnormal shoulder mobility. Physical exam reveals she can bring her shoulders together anteriorly. Radiographs show absent clavicles and delayed ossification of the pubic symphysis. Which transcription factor is mutated in this patient?

. SOX9
. RUNX2 (CBFA1)
. COMP
. GLI3
. SHH

Correct Answer & Explanation

. RUNX2 (CBFA1)


Explanation

Cleidocranial dysplasia is an autosomal dominant disorder caused by a mutation in the RUNX2 (CBFA1) gene, a master transcription factor for osteoblast differentiation. It is characterized by clavicular aplasia or hypoplasia and delayed dental eruption.

Question 3804

Topic: Biology, Genetics & Bone Healing

A 22-year-old female presents with severe back pain and neurological deficits. Imaging reveals a large, expansile, aneurysmal bone cyst in the sacrum that is deemed surgically unresectable. Which of the following medical therapies targets the RANKL pathway and is most appropriate for this lesion?

. Zoledronic acid
. Methotrexate
. Denosumab
. Imatinib
. Doxorubicin

Correct Answer & Explanation

. Denosumab


Explanation

Denosumab, a monoclonal antibody against RANKL, is highly effective in treating aggressive or surgically inaccessible aneurysmal bone cysts (ABCs) and giant cell tumors of bone. It inhibits osteoclast-like giant cells, leading to ossification of the cystic lesion.

Question 3805

Topic: Biology, Genetics & Bone Healing

A neonate presents with severe bowing of the tibias, respiratory distress due to tracheomalacia, and a 46,XY karyotype but female external genitalia. This condition is associated with a mutation in which of the following?

. COL2A1
. FGFR3
. SOX9
. SLC26A2
. EXT1

Correct Answer & Explanation

. SOX9


Explanation

Campomelic dysplasia is a rare, frequently lethal osteochondrodysplasia caused by mutations in the SOX9 gene. It is characterized by bowed long bones (especially the tibias), tracheomalacia, and sex reversal in approximately two-thirds of 46,XY individuals.

Question 3806

Topic: Biology, Genetics & Bone Healing

A 9-year-old girl is able to bring her shoulders together anteriorly in the midline. She has delayed eruption of her secondary teeth. Radiographs demonstrate absent clavicles and a widened symphysis pubis. Which transcription factor is mutated in this disorder?

. SOX9
. RUNX2 (CBFA1)
. IHH
. Wnt
. BMP-4

Correct Answer & Explanation

. RUNX2 (CBFA1)


Explanation

This is Cleidocranial Dysplasia, an autosomal dominant condition characterized by hypoplastic or absent clavicles, delayed fontanelle closure, and dental anomalies. It is caused by a mutation in the RUNX2 (also known as CBFA1) gene, an essential transcription factor for osteoblast differentiation.

Question 3807

Topic: Biology, Genetics & Bone Healing

A 4-year-old boy with recurrent fragility fractures, blue sclerae, and dentinogenesis imperfecta is treated with cyclic intravenous pamidronate. What is the expected and characteristic radiographic finding on long bone X-rays following multiple cycles of this therapy?

. Progressive anterolateral bowing of the diaphysis
. Dense, parallel transverse metaphyseal bands
. A generalized 'bone-within-bone' appearance
. Obliteration of the medullary canal
. Progressive radiolucency of the secondary ossification centers

Correct Answer & Explanation

. Dense, parallel transverse metaphyseal bands


Explanation

Bisphosphonates, such as pamidronate, inhibit osteoclast-mediated bone resorption. In growing children, cyclic administration produces dense transverse bands in the metaphyses (often called 'Zebra lines') corresponding to the periods of treatment.

Question 3808

Topic: Biology, Genetics & Bone Healing

A 68-year-old male presents with generalized fatigue, worsening back pain, and a recent humeral shaft fracture after a minor fall. Radiographs demonstrate multiple punched-out lytic lesions.

Which of the following factors is primarily responsible for the suppression of osteoblastic activity in this patient's disease process?

. Macrophage colony-stimulating factor (M-CSF)
. Dickkopf-1 (DKK-1)
. Vascular endothelial growth factor (VEGF)
. Fibroblast growth factor receptor 3 (FGFR3)
. Transforming growth factor-beta (TGF-beta)

Correct Answer & Explanation

. Dickkopf-1 (DKK-1)


Explanation

This patient has multiple myeloma, characterized by punched-out lytic lesions. Myeloma cells secrete DKK-1, which inhibits the Wnt signaling pathway, thereby suppressing osteoblast differentiation and activity.

Question 3809

Topic: Biology, Genetics & Bone Healing

Which of the following describes the earliest biochemical change occurring in the articular cartilage during the pathogenesis of osteoarthritis?

. Decreased water content and increased proteoglycan concentration
. Increased water content and decreased proteoglycan concentration
. Increased collagen type II concentration and decreased water content
. Decreased collagen type II concentration and increased proteoglycan concentration
. Increased chondrocyte apoptosis with decreased water content

Correct Answer & Explanation

. Increased water content and decreased proteoglycan concentration


Explanation

The earliest biochemical change in osteoarthritis is an increase in the water content of the articular cartilage. This is accompanied by a decrease in proteoglycan concentration and an alteration in the collagen network.

Question 3810

Topic: Biology, Genetics & Bone Healing

A 35-year-old male undergoes curettage and cementation of a giant cell tumor of the distal femur. Six months later, he develops a massive recurrence that is deemed unresectable. Medical therapy with denosumab is initiated. What is the mechanism of action of this medication?

. Direct inhibition of osteoclast proton pumps
. Monoclonal antibody against RANKL, preventing osteoclast activation
. Inhibition of the Wnt/beta-catenin pathway
. Tyrosine kinase inhibitor targeting CSF-1R
. Selective estrogen receptor modulation

Correct Answer & Explanation

. Monoclonal antibody against RANKL, preventing osteoclast activation


Explanation

Denosumab is a fully human monoclonal antibody that binds to RANKL, preventing it from activating RANK on the surface of osteoclasts and their precursors. This effectively halts the bone destruction mediated by the reactive osteoclasts in giant cell tumors.

Question 3811

Topic: Biology, Genetics & Bone Healing

A 10-month-old infant is evaluated for short stature, frontal bossing, and a waddling gait. Radiographs reveal widening of the physes, cupping of the metaphyses, and bowing of the long bones. Laboratory studies show normal calcium, low phosphorus, and elevated alkaline phosphatase. Which of the following describes the underlying histologic defect?

. Defect in type 1 collagen synthesis
. Failure of enchondral ossification due to FGFR3 mutation
. Failure of osteoid mineralization
. Defective osteoclast ruffled borders
. Hamartomatous proliferation of fibrous tissue

Correct Answer & Explanation

. Failure of osteoid mineralization


Explanation

The clinical and radiographic presentation is consistent with rickets. The fundamental histologic defect in rickets (and osteomalacia in adults) is the failure of osteoid mineralization, leading to widened, unmineralized growth plates.

Question 3812

Topic: Biology, Genetics & Bone Healing

A 30-year-old female presents with distal femur pain. Imaging reveals an eccentric, lytic, epiphyseal-metaphyseal lesion extending to the subchondral bone. Biopsy confirms Giant Cell Tumor (GCT). If medical therapy is considered, what is the mechanism of action of Denosumab?

. Directly induces apoptosis of the neoplastic mononuclear cells
. Binds to RANKL, inhibiting the maturation and function of osteoclast-like giant cells
. Inhibits VEGF to restrict tumor angiogenesis
. Functions as an alkylating agent cross-linking tumor DNA
. Stimulates osteoblast-mediated bone apposition around the tumor

Correct Answer & Explanation

. Binds to RANKL, inhibiting the maturation and function of osteoclast-like giant cells


Explanation

Denosumab is a monoclonal antibody that binds to RANKL. In GCT, the neoplastic mononuclear cells express RANKL, which recruits reactive osteoclast-like giant cells; Denosumab halts this recruitment and subsequent bone destruction.

Question 3813

Topic: Biology, Genetics & Bone Healing

A 70-year-old man presents with progressive hearing loss and increasing hat size. Radiographs demonstrate thickened cortices and coarsened trabeculae in the skull and pelvis. Paget's disease is diagnosed. The mixed phase of this disease is characterized by which of the following cellular activities?

. Predominant intense osteoclastic resorption with marrow fibrosis
. Coupled, massive increase in both osteoclastic and osteoblastic activity
. Predominant osteoblastic activity producing disorganized woven bone
. Malignant transformation of osteoblasts into osteoid-producing tumor cells
. Quiescent cellular activity with dense sclerotic bone remaining

Correct Answer & Explanation

. Coupled, massive increase in both osteoclastic and osteoblastic activity


Explanation

Paget's disease has three main phases: an initial lytic phase (intense osteoclastic activity), a mixed phase (simultaneous massive osteoclastic and osteoblastic activity), and a sclerotic phase (predominant osteoblastic activity with disorganized woven bone).

Question 3814

Topic: Biology, Genetics & Bone Healing

In the pathophysiology of multiple myeloma bone disease, which cytokine pathway is primarily responsible for the uncoupled osteoclast activation leading to the characteristic lytic lesions?

. Interleukin-1 (IL-1)
. Tumor Necrosis Factor-alpha (TNF-alpha)
. Interleukin-6 (IL-6)
. RANK/RANKL pathway
. Osteoprotegerin (OPG)

Correct Answer & Explanation

. RANK/RANKL pathway


Explanation

Myeloma cells overexpress RANKL and reduce Osteoprotegerin (OPG) secretion in the bone marrow microenvironment. This severe imbalance directly drives massive osteoclast activation and the resulting lytic bone destruction.

Question 3815

Topic: Biology, Genetics & Bone Healing

What is the first-line medical treatment for managing severe bone pain and improving clinical symptoms in patients with Camurati-Engelmann disease (progressive diaphyseal dysplasia)?

. Intravenous bisphosphonates
. Systemic corticosteroids
. Methotrexate
. Denosumab
. Indomethacin

Correct Answer & Explanation

. Systemic corticosteroids


Explanation

Systemic corticosteroids are the mainstay of medical treatment for progressive diaphyseal dysplasia. They have been shown to significantly reduce bone pain, improve fatigue, and sometimes reverse radiographic changes.

Question 3816

Topic: Biology, Genetics & Bone Healing

A 65-year-old male presents with severe mechanical back pain. A skeletal survey demonstrates multiple punched-out lytic lesions in the skull and spine.

Which of the following molecules, secreted by the malignant cells in this condition, is primarily responsible for the uncoupling of bone remodeling by directly inhibiting osteoblast differentiation?

. Macrophage inflammatory protein-1 alpha (MIP-1 alpha)
. Osteoprotegerin (OPG)
. Dickkopf-1 (DKK-1)
. Receptor activator of nuclear factor kappa-B ligand (RANKL)
. Interleukin-6 (IL-6)

Correct Answer & Explanation

. Dickkopf-1 (DKK-1)


Explanation

Multiple myeloma cells secrete Dickkopf-1 (DKK-1), which binds to LRP5/6 and inhibits the Wnt/beta-catenin signaling pathway. This prevents osteoblast differentiation, leading to purely lytic bone lesions without a blastic response.

Question 3817

Topic: Biology, Genetics & Bone Healing

A 28-year-old female presents with knee pain. Radiographs show an eccentric, lytic epiphyseal lesion in the distal femur. Biopsy reveals multinucleated giant cells interspersed among mononuclear spindle cells. She is prescribed denosumab. What is the precise cellular target and mechanism of this medication in her condition?

. It directly binds to RANK receptors on the multinucleated giant cells
. It binds to RANKL produced by the neoplastic mononuclear stromal cells
. It inhibits the vascular endothelial growth factor (VEGF) receptor
. It directly induces apoptosis of the multinucleated giant cells
. It stimulates osteoprotegerin (OPG) production by osteoblasts

Correct Answer & Explanation

. It binds to RANKL produced by the neoplastic mononuclear stromal cells


Explanation

In Giant Cell Tumor of bone, the true neoplastic cells are the mononuclear stromal cells, which express high levels of RANKL. Denosumab binds to this RANKL, preventing it from recruiting and activating the reactive, osteoclast-like giant cells.

Question 3818

Topic: Biology, Genetics & Bone Healing

A 22-year-old female undergoes corrective osteotomy for a 'shepherd's crook' deformity of the proximal femur. Pathology demonstrates a stroma of bland spindle cells with irregularly shaped trabeculae of woven bone lacking osteoblastic rimming. This condition is caused by a somatic activating mutation in which gene?

. EXT1
. RUNX2
. GNAS
. SOX9
. PTEN

Correct Answer & Explanation

. GNAS


Explanation

The clinical and histologic description ('Chinese character' woven bone) is classic for Fibrous Dysplasia. This disease is caused by a somatic missense mutation in the GNAS gene, which encodes the stimulatory G-protein alpha subunit, leading to elevated cAMP levels.

Question 3819

Topic: Biology, Genetics & Bone Healing

A newborn is noted to have a large anterior fontanelle, delayed closure of cranial sutures, and hypermobility of the shoulders, allowing them to be approximated in the anterior midline. Radiographs reveal hypoplastic clavicles. This condition is caused by a mutation in a gene essential for the differentiation of which cell type?

. Osteoclasts
. Chondrocytes
. Osteoblasts
. Fibroblasts
. Synoviocytes

Correct Answer & Explanation

. Osteoblasts


Explanation

Cleidocranial dysplasia is caused by a mutation in RUNX2 (also known as CBFA1), a master transcription factor essential for osteoblast differentiation and intramembranous ossification (affecting the clavicles and skull).

Question 3820

Topic: Biology, Genetics & Bone Healing

A 32-year-old female presents with knee pain. Radiographs show an eccentric, purely lytic lesion in the distal femur epiphysis extending to the subchondral bone. A biopsy reveals multinucleated giant cells. Which of the following targeted therapies is most appropriate for unresectable disease?

. Imatinib
. Denosumab
. Rituximab
. Infliximab
. Doxorubicin

Correct Answer & Explanation

. Denosumab


Explanation

Giant Cell Tumor of bone consists of neoplastic stromal cells that express RANKL, which recruits osteoclast-like giant cells. Denosumab, a RANKL monoclonal antibody, is highly effective for unresectable or recurrent GCT.